In summary, to promote dyslipidemia management and effectively reduce the risk of CVD in postmenopausal women, studies involving different geographic regions, ethnic groups, and various lipid profiles should be conducted to determine the exact relationship and mechanism of action of FSH with serum lipids. This evidence concerns the gene BRD2 and metabolic syndrome.